References
- Ritchie MD . The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum. Genet.131(10) , 1615–1626 (2012).
- Welsh M , MangraviteL, MedinaMW et al. Pharmacogenomic discovery using cell-based models. Pharmacol. Rev. 61(4) , 413–429 (2009).
- Choy E , YelenskyR, BonakdarS et al. Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet. 4(11) , e1000287 (2008).
- Stark AL , ZhangW, MiS et al. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. Pharmacogenomics J. 10(6) , 505–512 (2010).
- Wheeler HE , DolanME. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Pharmacogenomics13(1) , 55–70 (2012).
- Huang RS , DuanS, KistnerEO, HartfordCM, DolanME. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol. Cancer Ther.7(9) , 3038–3046 (2008).
- Tan XL , MoyerAM, FridleyBL et al. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clin. Cancer Res. 17(17) , 5801–5811 (2011).
- Duan S , BleibelWK, HuangRS et al. Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res. 67(11) , 5425–5433 (2007).
- Watson VG , Motsinger-ReifA, HardisonNE et al. Identification and replication of loci involved in camptothecin-induced cytotoxicity using CEPH pedigrees. PLoS ONE 6(5) , e17561 (2011).
- Brown CC , HavenerTM, MedinaMW et al. A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT. Pharmacogenet. Genomics 22(11) , 796–802 (2012).
- Li L , FridleyB, KalariK et al. Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. Cancer Res. 68(17) , 7050–7058 (2008).
- Peters EJ , Motsinger-ReifA, HavenerTM et al. Pharmacogenomic characterization of US FDA-approved cytotoxic drugs. Pharmacogenomics 12(10) , 1407–1415 (2011).
- Ziliak D , O‘DonnellPH, ImHK et al. Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. Transl. Res. 157(5) , 265–272 (2011).
- Watson VG , HardisonNE, HarrisT, Motsinger-ReifA, McLeodHL. Genomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolines. Mol. Cancer Ther.10(10) , 1839–1845 (2011).
- Dausset J , CannH, CohenD, LathropM, LalouelJM, WhiteR. Centre d‘Etude du Polymorphisme Humain (CEPH): collaborative genetic mapping of the human genome. Genomics6(3) , 575–577 (1990).
- Brown CC , HavenerTM, MedinaMW, KraussRM, McLeodHL, Motsinger-ReifAA. Multivariate methods and software for association mapping in dose–response genome-wide association studies. BioData Min.5(1) , 21 (2012).
- Medina MW , GaoF, RuanW, RotterJI, KraussRM. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation118(4) , 355–362 (2008).
- Barber MJ , MangraviteLM, HydeCL et al. Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS ONE 5(3) , e9763 (2010).
- Li Y , WillerC, SannaS, AbecasisG. Genotype imputation. Annu. Rev. Genomics Hum. Genet.10 , 387–406 (2009).
- Purcell S , NealeB, Todd-BrownK et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81(3) , 559–575 (2007).
- Laurie CC , DohenyKF, MirelDB et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet. Epidemiol. 34(6) , 591–602 (2010).
- Price AL , PattersonNJ, PlengeRM, WeinblattME, ShadickNA, ReichD. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet.38(8) , 904–909 (2006).
- Brown C , HavenerTM, EverittL, McLeodH, Motsinger-ReifAA. A comparison of association methods for cytotoxicity mapping in pharmacogenomics. Front. Genet.2 , 86 (2011).
- Pillai K . Some new test criteria in multivariate analysis. Ann. Math. Statist.26(1) , 117–121 (1955).
- Li MX , YeungJM, ChernySS, ShamPC. Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets. Hum. Genet.131(5) , 747–756 (2012).
- R Development Core Team. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Austria (2011).
- Schmidt WM , KalipciyanM, DornstauderEet al. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int. J. Cancer 112(2) , 200–212 (2004).
- Shabason JE , TofilonPJ, CamphausenK. Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic. J. Cell. Mol. Med.15(12) , 2735–2744 (2011).